148 related articles for article (PubMed ID: 25894363)
1. Lewis acid-induced intramolecular access to novel steroidal ring D-condensed arylpyrazolines exerting in vitro cell-growth-inhibitory effects.
Mótyán G; Zupkó I; Minorics R; Schneider G; Wölfling J; Frank É
Mol Divers; 2015 Aug; 19(3):511-27. PubMed ID: 25894363
[TBL] [Abstract][Full Text] [Related]
2. Efficient approach to androstene-fused arylpyrazolines as potent antiproliferative agents. Experimental and theoretical studies of substituent effects on BF(3)-catalyzed intramolecular [3 + 2] cycloadditions of olefinic phenylhydrazones.
Frank E; Mucsi Z; Zupkó I; Réthy B; Falkay G; Schneider G; Wölfling J
J Am Chem Soc; 2009 Mar; 131(11):3894-904. PubMed ID: 19245200
[TBL] [Abstract][Full Text] [Related]
3. Microwave-assisted stereoselective approach to novel steroidal ring D-fused 2-pyrazolines and an evaluation of their cell-growth inhibitory effects in vitro.
Mótyán G; Kovács F; Wölfling J; Gyovai A; Zupkó I; Frank É
Steroids; 2016 Aug; 112():36-46. PubMed ID: 27154752
[TBL] [Abstract][Full Text] [Related]
4. Investigation of pH and substituent effects on the distribution ratio of novel steroidal ring D- and A-fused arylpyrazole regioisomers and evaluation of their cell-growth inhibitory effects in vitro.
Baji Á; Kovács F; Mótyán G; Schneider G; Wölfling J; Sinka I; Zupkó I; Ocsovszki I; Frank É
Steroids; 2017 Oct; 126():35-49. PubMed ID: 28803210
[TBL] [Abstract][Full Text] [Related]
5. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel 17-(4'-formyl)pyrazolylandrosta-5,16-dienes and their derivatives as potent 17α-hydroxylase/C17,20-lyase inhibitors or antiproliferative agents depending on the substitution pattern of the heteroring.
Kovács D; Wölfling J; Szabó N; Szécsi M; Schelz Z; Zupkó I; Frank É
Eur J Med Chem; 2016 Sep; 120():284-95. PubMed ID: 27209562
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Baek D; Choi J; Lee H; Oh CH
J Enzyme Inhib Med Chem; 2016; 31(sup2):111-122. PubMed ID: 27255180
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives.
El-Gamal MI; Abdel-Maksoud MS; Gamal El-Din MM; Shin JS; Lee KT; Yoo KH; Oh CH
Anticancer Agents Med Chem; 2017; 17(1):75-84. PubMed ID: 27334850
[TBL] [Abstract][Full Text] [Related]
9. Anti-Cancer Activity of Novel Dihydrotestosterone-Derived Ring A-Condensed Pyrazoles on Androgen Non-Responsive Prostate Cancer Cell Lines.
Mótyán G; Gopisetty MK; Kiss-Faludy RE; Kulmány Á; Zupkó I; Frank É; Kiricsi M
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052484
[TBL] [Abstract][Full Text] [Related]
10. Facile and efficient access to Androsten-17-(1',3',4')-pyrazoles and Androst-17β-(1',3',4')-pyrazoles via Vilsmeier reagents, and their antiproliferative activity evaluation in vitro.
Li J; Huo H; Guo R; Liu B; Li L; Dan W; Xiao X; Zhang J; Shi B
Eur J Med Chem; 2017 Apr; 130():1-14. PubMed ID: 28237792
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of D-ring-substituted (5'R)- and (5'S)-17β-pyrazolinylandrostene epimers and comparison of their potential anticancer activities.
Iványi Z; Szabó N; Huber J; Wölfling J; Zupkó I; Szécsi M; Wittmann T; Schneider G
Steroids; 2012 Apr; 77(5):566-74. PubMed ID: 22342542
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of unprecedented steroidal spiro heterocycles as potential antiproliferative drugs.
Romero-Hernández LL; Merino-Montiel P; Meza-Reyes S; Vega-Baez JL; López Ó; Padrón JM; Montiel-Smith S
Eur J Med Chem; 2018 Jan; 143():21-32. PubMed ID: 29172080
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF
Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of new pyrazole derivatives and their anticancer evaluation.
Nitulescu GM; Draghici C; Missir AV
Eur J Med Chem; 2010 Nov; 45(11):4914-9. PubMed ID: 20728965
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative activity of D-ring substituted steroidal benzamidothiazoles.
Fan NJ; He QR; Duan M; Bai YB; Tang JJ
Steroids; 2016 Aug; 112():103-8. PubMed ID: 27137356
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxic activity of some novel steroidal C-17 pyrazolinyl derivatives.
Fan NJ; Tang JJ; Li H; Li XJ; Luo B; Gao JM
Eur J Med Chem; 2013 Nov; 69():182-90. PubMed ID: 24021891
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro antitumor activity of a novel series of 2-pyrazoline derivatives bearing the 4-aryloxy-7-chloroquinoline fragment.
Montoya A; Quiroga J; Abonia R; Nogueras M; Cobo J; Insuasty B
Molecules; 2014 Nov; 19(11):18656-75. PubMed ID: 25405285
[TBL] [Abstract][Full Text] [Related]
20. Multistep Synthesis and In Vitro Anticancer Evaluation of 2-Pyrazolyl-Estradiol Derivatives, Pyrazolocoumarin-Estradiol Hybrids and Analogous Compounds.
Molnár B; Gopisetty MK; Adamecz DI; Kiricsi M; Frank É
Molecules; 2020 Sep; 25(18):. PubMed ID: 32899643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
